Literature DB >> 31750102

Isovolumetric Relaxation Time (IVRT): An Effective Tool in Management of Subclinical Hypothyroidism.

Gaddada Devara Mutt Basavaraj Jyothi Prakash1, Uttarkar Pandurangarao Santosh2, Janarthanan Sridurga2.   

Abstract

Hypothyroidism is a common condition in which thyroid gland doesn't produce sufficient thyroid hormone. Normal range of TSH is 0.4 to 4 mIU/L. Patients with TSH between 5 and 10 mIU/L, with normal T4 are diagnosed to have subclinical hypothyroidism. Decision to treat, particularly the subclinical hypothyroidism is tailored to individual patients. In our study, isovolumetric relaxation time (IVRT) was used to detect the diastolic function of cardia in hypothyroid patient, with the help of 2D echocardiogram. Normal duration of IVRT is 54 to 65 μs and in hypothyroidism it is expected to increase. To assess, whether IVRT is an effective tool in the management of subclinical hypothyroidism. 50 patients attending otorhinolaryngology OPD with TSH level of 5 to 10 mIU/L were selected for the study. All these were sent for 2D echocardiogram, for the measurement of IVRT. These 50 patients were divided into 2 groups. Group A-patients with TSH level 5 to 10 mIU/L and normal IVRT. Group B-patients with TSH level 5 to 10 mIU/L and prolonged IVRT. Patients in Group A were not given thyroxine, and after 3 months, they were reviewed with TSH level and IVRT duration. Patients in Group B were started with thyroxine, and after 3 months, they were reviewed with TSH level and IVRT duration. The basal and 3 months follow up values of TSH and IVRT was analysed on both the groups. The p value of group A was not significant, but p value group B was significant. IVRT as a measuring tool in sub clinical hypothyroidism will definitely bring a major change in the concepts of treatment. © Association of Otolaryngologists of India 2019.

Entities:  

Keywords:  2D echocardiogram; IVRT; Subclinical hypothyroidism; Thyroxine

Year:  2019        PMID: 31750102      PMCID: PMC6838295          DOI: 10.1007/s12070-019-01615-z

Source DB:  PubMed          Journal:  Indian J Otolaryngol Head Neck Surg        ISSN: 2231-3796


  8 in total

1.  Thyroid hormone regulation of phospholamban phosphorylation in the rat heart.

Authors:  K Ojamaa; A Kenessey; I Klein
Journal:  Endocrinology       Date:  2000-06       Impact factor: 4.736

Review 2.  Thyroid hormone regulation of calcium cycling proteins.

Authors:  Andrew N Carr; Evangelia G Kranias
Journal:  Thyroid       Date:  2002-06       Impact factor: 6.568

3.  Translational implications of nongenomic actions of thyroid hormone initiated at its integrin receptor.

Authors:  Paul J Davis; Faith B Davis; Hung-Yun Lin; Shaker A Mousa; Min Zhou; Mary K Luidens
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-09-15       Impact factor: 4.310

4.  Effect of serum triiodothyronine on regulation of cardiac gene expression: role of histone acetylation.

Authors:  Sara Danzi; Peter Dubon; Irwin Klein
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-05-13       Impact factor: 4.733

5.  Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III).

Authors:  Joseph G Hollowell; Norman W Staehling; W Dana Flanders; W Harry Hannon; Elaine W Gunter; Carole A Spencer; Lewis E Braverman
Journal:  J Clin Endocrinol Metab       Date:  2002-02       Impact factor: 5.958

Review 6.  Age- and race-based serum thyrotropin reference limits.

Authors:  Martin I Surks; Laura Boucai
Journal:  J Clin Endocrinol Metab       Date:  2009-12-04       Impact factor: 5.958

Review 7.  Hypothyroidism as a risk factor for cardiovascular disease.

Authors:  Bernadette Biondi; Irwin Klein
Journal:  Endocrine       Date:  2004-06       Impact factor: 3.633

Review 8.  Thyroid disease and the heart.

Authors:  Irwin Klein; Sara Danzi
Journal:  Circulation       Date:  2007-10-09       Impact factor: 29.690

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.